HiSeq Sales Boost Illumina's Q3 Revenues, but Order Backlog Will Take Several Quarters to Fill
November 02, 2010
HiSeq Sales Boost Illumina's Q3 Revenues, but Order Backlog Will Take Several Quarters to Fill
The company is also updating its portfolio of sequencers: It launched the HiSeq 1000, reduced the list price for the GAIIx, and said it will discontinue the GAIIe.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.